• Home
  •  
    Regions
    • Europe
    • UK & Ireland
    • DACH
    • Nordic
    • France
    • Southern Europe
    • Benelux
    • CEE
    • Asia
  •  
    Deals
    • Buyouts
    • Venture
    • Exits
    • Refinancings
    • Build-up
    • Turnaround
    • Secondaries
    • Advanced deal search
  •  
    Funds
    • Buyout
    • Venture
    • Mezzanine
    • Debt
    • Funds-of-funds
    • Secondaries
    • Fundraising pipelines
    • Advanced funds search
  •  
    GPs & LPs
    • GP profiles
    • LP profiles
    • GP news
    • LP news
    • Sponsors search
    • LPs search
  •  
    Secondaries
    • Deals
    • Funds
    • News
    • Analysis
  •  
    People
    • Q&A
    • Videos
    • Comment
    • Analysis
    • People moves
    • In Profile
  •  
    Analysis
    • Videos
    • Q&A
    • Comment
    • In Profile
    • Podcast
    • Fundraising
    • Reports
    • Data Snapshots
  •  
    Unquote Data
    • Deals search
    • Exits search
    • Funds search
    • Sponsors search
    • Advisers search
    • LPs search
    • League tables
    • Reports
  • Sign in
  • Sign in
    • You are currently accessing unquote.com via your Enterprise account.

      If you already have an account please use the link below to sign in.

      If you have any problems with your access or would like to request an individual access account please contact our customer service team.

      Phone: +44 (0)203 741 1137

      Email: Georgina.Lawson@acuris.com

      • Sign in
     
      • Newsletters
      • Account details
      • Contact support
      • Sign out
     
  • Follow us
    • Twitter
    • LinkedIn
  • Free Trial
  • Subscribe
Unquote
Unquote
  • Home
  • Regions
  • Deals
  • Funds
  • GPs & LPs
  • Secondaries
  • People
  • Analysis
  • Unquote Data
      • Deals search
      • Exits search
      • Funds search
      • Sponsors search
      • Advisers search
      • LPs search
      • League tables
      • Reports
  • You are currently accessing unquote.com via your Enterprise account.

    If you already have an account please use the link below to sign in.

    If you have any problems with your access or would like to request an individual access account please contact our customer service team.

    Phone: +44 (0)203 741 1137

    Email: Georgina.Lawson@acuris.com

    • Sign in
 
    • Newsletters
    • Account details
    • Contact support
    • Sign out
 
UNQUOTE
  • Exits

Turkven completes Medical Park listing on Borsa Istanbul

  • Nicole Tovstiga
  • Nicole Tovstiga
  • 08 February 2018
  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Send to  

Turkish GP Turkven has listed hospital group Medical Park on the Borsa Istanbul with a $1.02bn market cap.

The Turkey-headquartered GP made a full exit selling 72.8 million shares, including overallotment against demand for 89.2 million shares.

The offering was set at 19 lira per share, after initially being priced at up to 28.8 lira. Following low demand and sharp drops on global stock markets, the IPO price range was revised down to 19-20 lira.

Together with the capital raise, the company netted TRY 600m in gross proceeds through the listing. These would be used to reduce net debt by repaying foreign-currency-denominated debt arising from the company's syndicated loan facilities, according to the firm.

Sold shares represented 36.15% of Medical Park's total capital, earning the seller around TRY 1.38bn ($370m) out of a total valuation of TRY 3.83bn ($1.02bn).

Of the sold shares, 83.5% of the offered shares sold to a total of 30 international institutional investors, and the remainder was sold to 69 domestic institutional investors and a further 5,252 individual investors.

Temasek bought 9.95 million shares (15.7%), Genesis Investment 7.36 million (11.6%), Charlemagne Capital 6.5 million shares (10.3%), Carrhae Capital 5.25 million (8.3%), AllianceBernstein 4.42 million (7%), Goldman Sachs 3.68 million (5.8%), and East Capital 3.38 million (5.3%).

Trading will commence on 13 February. AK Investment acted as bookrunner for the offering.

Previous funding
Carlyle initially invested in the hospital group in December 2009, picking up a 40% stake in an all-equity deal via its MENA fund. In January 2014, Turkven acquired Carlyle's 40% holding. The deal saw the company's other investors, Sancak Group and Usta Group, also partially sell their interests.

Unquote reported Turkven's intentions to float Medical Park in August 2017, marking the end of the GP's ownership after a three-year holding. 

Company
Medical Park was established in 2005 through a partnership between two existing hospitals based in Istanbul. It operates with 1,750 physicians, 15,000 employees and 4,900 beds across 29 hospitals.

People
Turkven – Seymur Tari (founder, CEO).

  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Send to  
  • Topics
  • Exits
  • CEE
  • Healthcare
  • Turkey
  • Turkven Private Equity
  • IPO

More on Exits

Partners Group to release IMs for Civica sale in mid-September
Partners Group to release IMs for Civica sale in mid-September

Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017

  • Exits
  • 04 September 2023
Actera Group explores strategic options for Celebi Ground Handling
Actera Group explores strategic options for Celebi Ground Handling

Several investors placed bids for the company in 2022 but mismatch in pricing didn't lead to a deal

  • Exits
  • 30 August 2023
Norstat owner Triton Partners explores sale via William Blair
Norstat owner Triton Partners explores sale via William Blair

GP has owned the Norway-headquarterd market research business for almost four years

  • Exits
  • 25 August 2023
IK Investment-backed Eres expected to hit the auction block by 2024
IK Investment-backed Eres expected to hit the auction block by 2024

French employee savings distribution and management firm could be valued at a few hundred million euros

  • Exits
  • 24 August 2023

Latest News

Partners Group to release IMs for Civica sale in mid-September
  • Exits
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme

Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017

  • 04 September 2023
BHM Group builds on PE strategy, eyes European medtech and renewable energy acquisitions
  • Investments
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme

Czech Republic-headquartered family office is targeting DACH and CEE region deals

  • 01 September 2023
Redalpine expands leadership team amid CHF 1bn-plus fundraise
  • Venture
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme

Ex-Rocket Internet leader Bettina Curtze joins Swiss VC firm as partner and CFO

  • 31 August 2023
Change Ventures aims to hold final close for EUR 20m third fund by mid-2024
  • Funds
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme

Estonia-registered VC could bolster LP base with fresh capital from funds-of-funds or pension funds

  • 31 August 2023
Back to Top
  • About Unquote
  • Advertise
  • Contacts
  • About Acuris
  • Terms of Use
  • Privacy Policy
  • Group Disclaimer
  • Twitter
  • LinkedIn

© Merger Market

© Mergermarket Limited, 10 Queen Street Place, London EC4R 1BE - Company registration number 03879547

Digital publisher of the year 2010 & 2013

Digital publisher of the year 2010 & 2013